K
Karim Chamie
Researcher at University of California, Los Angeles
Publications - 181
Citations - 4838
Karim Chamie is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Bladder cancer & Cancer. The author has an hindex of 31, co-authored 161 publications receiving 3459 citations. Previous affiliations of Karim Chamie include UCLA Medical Center & University of California, Davis.
Papers
More filters
Journal ArticleDOI
Bladder Cancer: A Review
TL;DR: Improved understanding of the molecular biology and genetics of bladder cancer has evolved the way localized and advanced disease is diagnosed and treated, and the therapeutic options has expanded to include immunotherapy with checkpoint inhibition, targeted therapies, and antibody-drug conjugates.
Journal ArticleDOI
Recurrence of high-risk bladder cancer: a population-based analysis.
Karim Chamie,Mark S. Litwin,Jeffrey C. Bassett,Timothy J. Daskivich,Julie Lai,Jan M. Hanley,Badrinath R. Konety,Christopher S. Saigal,Christopher S. Saigal +8 more
TL;DR: In this article, the recurrence, progression, and bladder cancer-related mortality rates were examined in a cohort of individuals with high-grade non-muscle-invasive bladder cancer.
Journal ArticleDOI
Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008.
Nicholas M. Donin,Christopher P. Filson,Christopher P. Filson,Alexandra Drakaki,Hung-Jui Tan,Alex Castillo,Lorna Kwan,Mark S. Litwin,Karim Chamie +8 more
TL;DR: In the current study, the authors attempted to describe the incidence, most common sites, and mortality of second primary malignancies among survivors of common cancers.
Journal ArticleDOI
Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage.
Kirk A. Keegan,Clayton W. Schupp,Karim Chamie,Nicholas J. Hellenthal,Christopher P. Evans,Theresa M. Koppie +5 more
TL;DR: Renal cell carcinoma histological subtype predicts overall and cancer specific survival and patients with collecting duct and sarcomatoid variants of renal cell carcinomas have poor survival, even those who present with low stage disease.
Journal ArticleDOI
Compliance with guidelines for patients with bladder cancer: variation in the delivery of care.
Karim Chamie,Christopher S. Saigal,Christopher S. Saigal,Julie Lai,Jan M. Hanley,Claude Messan Setodji,Badrinath R. Konety,Mark S. Litwin +7 more
TL;DR: Practice patterns in patients with high‐grade non‐muscle‐invasive bladder cancer are characterized in relation to established guidelines.